Ctx Gls 200 MG Injection 1

Ctx Gls 200 MG Injection 1 is used for the following:

• Treatment of various types of cancer

• Management of lymphomas

• Therapy for leukaemia

• Treatment of breast cancer

• Management of ovarian cancer

• Therapy for non-small cell lung cancer

• Treatment of treatment-resistant nephrotic syndrome

• Management of severe autoimmune conditions

• Suppression of harmful immune responses

• Reduction of kidney inflammation in children

• Used in certain types of nephrotic syndrome (e.g., steroid-resistant forms), especially in children, to reduce proteinuria by suppressing immune-mediated kidney damage

Follow these instructions when receiving Ctx Gls 200 MG Injection 1:

• This medicine must only be administered by qualified healthcare professionals.

• The injection is given through slow intravenous infusion in a hospital setting.

• Report any discomfort during administration to your doctor immediately.

• Follow all post-injection care instructions provided by your medical team.

• Consult your doctor about any concerns regarding the administration process.

Ctx Gls 200 MG Injection 1 is administered intravenously.

Ctx Gls 200 MG Injection 1 contains cyclophosphamide (200 mg), which works on the body as follows:

• DNA cross-linking: Cyclophosphamide is metabolized in the liver to form compounds that form links between DNA strands in cells. This prevents cells from dividing properly, particularly affecting fast-growing cancer cells.

• Programmed cell death: The medicine triggers a process called programmed cell death (apoptosis) in rapidly dividing cells, helping to destroy cancer cells throughout the body.

• Immunosuppression: Cyclophosphamide reduces the activity of your immune system by decreasing antibody production and lowering the number of certain white blood cells. This helps manage conditions where the immune system is overactive.

• Reduces protein leakage: The medicine helps reduce protein leakage in nephrotic syndrome by suppressing the overactive immune response that contributes to kidney damage.

• Keep Ctx Gls 200 MG Injection 1 in its original packaging until use.

• Store in a cool, dry place.

• Protect from direct sunlight and excessive heat.

• Keep this medicine out of sight and reach of children.

• Do not use after the expiry date printed on the packaging.

• Follow the guidelines of the healthcare facility for handling this medicine.

• During cancer treatment with Ctx Gls 200 MG Injection 1, maintain adequate fluid intake (at least 2-3 litres daily) to help reduce the risk of bladder irritation and flush out harmful metabolites.

• If you experience appetite loss due to the medicine, try eating smaller, more frequent meals throughout the day rather than three large meals to ensure proper nutrition.